Thymidine
- Generic Name
- Thymidine
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C10H14N2O5
- CAS Number
- 50-89-5
- Unique Ingredient Identifier
- VC2W18DGKR
- Background
Thymidine is a pyrimidine deoxynucleoside. Thymidine is the DNA nucleoside T, which pairs with deoxyadenosine (A) in double-stranded DNA. In cell biology it is used to synchronize the cells in S phase.
- Associated Conditions
- -
- Associated Therapies
- -
Treatment of TK2 Deficiency With Thymidine and Deoxycytidine
Phase 1
Active, not recruiting
- Conditions
- Thymidine Kinase 2 DeficiencyMitochondrial DNA Depletion Syndrome 2 Myopathic Type
- Interventions
- First Posted Date
- 2018-08-21
- Last Posted Date
- 2024-01-22
- Lead Sponsor
- Columbia University
- Target Recruit Count
- 23
- Registration Number
- NCT03639701
- Locations
- 🇺🇸
Columbia University Irving Medical Center, New York, New York, United States
Phase II Study of Ribose, Uridine, and Thymidine for a Complex Syndrome Involving Excessive 5'-Nucleotidase Activity
Phase 2
Completed
- Conditions
- 5'-Nucleotidase Syndrome
- First Posted Date
- 2000-02-25
- Last Posted Date
- 2005-06-24
- Lead Sponsor
- National Center for Research Resources (NCRR)
- Registration Number
- NCT00004658
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath